Can Caffeine Prevent Spinal Multiple Sclerosis?

Spinal multiple sclerosis—technically known as myelitis within the broader condition of multiple sclerosis (MS)—is among the most physically debilitating forms of the disease. For patients and researchers alike, preventing or delaying its onset remains a critical goal. A recent discovery involving caffeine and mice offers a surprising clue about how we might defend against a key animal model of the disease.

Yes, according to U.S. researchers, daily caffeine intake—equivalent to 6 to 8 cups of coffee per day for a human—can help prevent mice from developing experimental autoimmune encephalomyelitis (EAE), the animal version of human spinal MS. This effect is likely due to caffeine blocking immune cells from entering the central nervous system.

What Is Experimental Autoimmune Encephalomyelitis (EAE)?

EAE is the most widely used animal model for studying human spinal multiple sclerosis. Like spinal MS, EAE is an autoimmune disorder in which the immune system mistakenly attacks the body’s own tissues—in this case, the brain and spinal cord nerves, leading to inflammation and damage. It’s not identical to human MS, but it replicates many of the critical disease mechanisms, especially those affecting the spinal cord.

How Does Caffeine Affect the Immune Response?

Researchers at Cornell University, led by Jeffrey Mills, found that mice given a daily dose of caffeine corresponding to 6–8 cups of coffee were significantly less likely to develop EAE. The mechanism appears to involve caffeine’s interaction with adenosine receptors. Adenosine is a molecule naturally present throughout the body and involved in processes like energy transfer and sleep regulation. In the context of MS and EAE, adenosine helps immune cells cross into the central nervous system. Caffeine works by binding to the same adenosine receptors, effectively blocking adenosine’s action and thus preventing immune cells from infiltrating where they shouldn’t.

The Role of Adenosine and CD73 Enzyme

Additional findings from the study revealed that mice lacking adenosine receptors or the CD73 enzyme—which is essential for producing adenosine outside of cells—were also resistant to developing EAE. This suggests that both adenosine signaling and its enzymatic production pathways are critical in the development of the disease. These insights, combined with caffeine’s receptor-blocking effects, open potential avenues for developing new preventive or therapeutic strategies targeting the adenosine pathway in spinal MS.

Current Treatments for Spinal Multiple Sclerosis

Treatment for spinal MS typically occurs in two phases. Acute phase therapies often include corticosteroids such as methylprednisolone, dexamethasone, and prednisone, along with intravenous immunoglobulin and B vitamins—mainly B1 and B12. For patients with comorbidities like diabetes or ulcers, doctors may opt for immunosuppressants like azathioprine or cyclophosphamide instead. During remission phases, interferon may be used to prevent relapse. In cases where all else fails, autologous stem cell transplantation is considered an option.

Stem cells, which can self-renew and differentiate into various functional cell types, are sometimes referred to as “universal cells” or “source cells” due to their plasticity. Stem cell therapy for spinal MS has been in clinical use since the 1950s, primarily through hematopoietic stem cell transplants. By 2005, it was listed among the world’s top ten most promising medical breakthroughs.

Why This Research Matters

While the study was conducted on mice, the implications for human spinal MS are significant. The role of adenosine and its receptors in immune cell infiltration offers a plausible biochemical pathway for intervention. Caffeine, a widely consumed and generally safe compound, could serve as a starting point for drug development—or at least as a dietary factor worth examining further in human studies.

Frequently Asked Questions

How much caffeine did the mice receive in the study?

The mice were given amounts of caffeine equivalent to a human drinking 6 to 8 cups of coffee per day. This level of intake was sufficient to reduce their likelihood of developing EAE, the mouse model of spinal multiple sclerosis.

What is experimental autoimmune encephalomyelitis (EAE)?

EAE is an autoimmune disease in mice that mimics many aspects of human spinal multiple sclerosis. It involves the immune system attacking the central nervous system, particularly the spinal cord and brain, causing inflammation and nerve damage.

How does caffeine block immune cells in the study?

Caffeine blocks adenosine receptors in the central nervous system. Since adenosine normally helps immune cells enter the CNS, caffeine’s presence prevents this process, reducing the likelihood of autoimmune attack on spinal nerves.

Can drinking coffee prevent spinal multiple sclerosis in humans?

The study showed a preventive effect in mice, not humans. While the mechanism is promising, more research is needed to determine whether similar effects occur in people or if caffeine could play a role in human MS prevention strategies.

What other treatments exist for spinal multiple sclerosis?

Treatments include corticosteroids like methylprednisolone during acute phases, immunosuppressants for certain patients, interferon during remission, and experimental approaches like autologous stem cell transplantation for severe or treatment-resistant cases.

Recommended FrontStreet Beans for Neuro Health Support

While no coffee directly treats neurological conditions, FrontStreet Coffee’s Ethiopia Humbera offers bright, complex fruit and floral notes with a tea-like body—ideal for mental clarity. Their PWN Golden Mandheling delivers a heavy body and sweet, nutty profile, great for sustained focus. Finally, Kenya Little Tomato brings vibrant acidity and berry tones to keep your mind alert. All three are single-origin, carefully roasted, and support a healthy coffee routine. Freshly roasted within 5 days · Orders placed before 17:00 ship the same day · Next-day delivery across most of Guangdong Province.